Aprocitentan. Dual endothelin ETA/ETB receptor antagonist, Treatment of resistant hypertension
-
Published:2021
Issue:8
Volume:46
Page:595
-
ISSN:0377-8282
-
Container-title:Drugs of the Future
-
language:en
-
Short-container-title:Drugs Fut
Author:
Warden B.A.,Duell P.B.
Subject
Pharmacology (medical),Pharmacology